| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | G C DeLuca | Q64857015 |
| Harry Beale | Q86334379 | ||
| P2093 | author name string | Sarah A Morrow | |
| Richard L Yates | |||
| P2860 | cites work | Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats | Q45799560 |
| Neocortical interneurons: functional diversity and clinical correlations | Q45837036 | ||
| Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction | Q45866204 | ||
| Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology. | Q45936301 | ||
| Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. | Q46023385 | ||
| Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline | Q46390363 | ||
| Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis | Q47203630 | ||
| Evidence of axonal damage in human acute demyelinating diseases | Q47234264 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Alzheimer's Disease | Q22248111 | ||
| Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” | Q22252938 | ||
| Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis | Q24681662 | ||
| The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects | Q26851476 | ||
| The pathobiology of vascular dementia | Q27006033 | ||
| Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies | Q28140388 | ||
| Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years | Q28191390 | ||
| Pathological abnormalities in the normal-appearing white matter in multiple sclerosis | Q28198901 | ||
| Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis | Q28215006 | ||
| Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis | Q28252596 | ||
| Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis | Q28275482 | ||
| Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction | Q28276538 | ||
| Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis | Q28284268 | ||
| Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord | Q28295737 | ||
| The blood-brain barrier in cortical multiple sclerosis lesions | Q28296839 | ||
| Cognitive impairment in multiple sclerosis | Q28300777 | ||
| Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques | Q29028192 | ||
| Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences. | Q47396020 | ||
| Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. | Q47596113 | ||
| Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients | Q47660422 | ||
| Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration | Q47680006 | ||
| Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords | Q48099284 | ||
| Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. | Q48109147 | ||
| Oligodendrocyte reactions and cell proliferation markers in human demyelinating diseases | Q48116208 | ||
| Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. | Q48174481 | ||
| The influence of pre-morbid IQ on Mini-Mental State Examination score at time of dementia presentation | Q48230915 | ||
| Subpial demyelination in the cerebral cortex of multiple sclerosis patients | Q48233815 | ||
| Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration | Q48336180 | ||
| Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study | Q48365771 | ||
| Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis | Q48366273 | ||
| Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study | Q48369385 | ||
| Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications | Q48379680 | ||
| Neocortical neuronal, synaptic, and glial loss in multiple sclerosis | Q48413281 | ||
| Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis | Q48450463 | ||
| Memory performance in multiple sclerosis patients correlates with central brain atrophy | Q48450471 | ||
| Thalamic neurodegeneration in multiple sclerosis | Q48459257 | ||
| Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis | Q48459611 | ||
| Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis | Q48485900 | ||
| Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis | Q48540910 | ||
| Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions | Q48550535 | ||
| Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits? | Q48559489 | ||
| The contribution of demyelination to axonal loss in multiple sclerosis | Q48592494 | ||
| Protein co-expression with axonal injury in multiple sclerosis plaques. | Q48612342 | ||
| Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis | Q48619606 | ||
| Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis | Q48709950 | ||
| Cortical demyelination and diffuse white matter injury in multiple sclerosis. | Q48726181 | ||
| Postmortem verification of MS cortical lesion detection with 3D DIR. | Q48728637 | ||
| Interpreting patient/informant discrepancies of reported cognitive symptoms in MS. | Q48738859 | ||
| Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue | Q48744978 | ||
| Monocyte/macrophage differentiation in early multiple sclerosis lesions | Q48752790 | ||
| Optimizing the association between disability and biological markers in MS. | Q48760386 | ||
| Axonal loss in normal-appearing white matter in a patient with acute MS. | Q48760400 | ||
| Axonal damage in acute multiple sclerosis lesions | Q48776354 | ||
| Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions | Q48777649 | ||
| Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions | Q48791086 | ||
| Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis | Q48801405 | ||
| Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. | Q48876836 | ||
| Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss | Q48906919 | ||
| The midline and intralaminar thalamic nuclei: anatomic and functional specificity and implications in neurologic disease | Q48923871 | ||
| Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis | Q48949792 | ||
| Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. | Q48958924 | ||
| Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. | Q50515193 | ||
| Unemployment in multiple sclerosis: the contribution of personality and disease. | Q50596740 | ||
| Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country. | Q50784220 | ||
| Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). | Q50892515 | ||
| Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location. | Q51018033 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. | Q51545443 | ||
| Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients. | Q51848380 | ||
| Regional hippocampal atrophy in multiple sclerosis. | Q51960814 | ||
| Memory decline evolves independently of disease activity in MS. | Q51963829 | ||
| Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. | Q51964603 | ||
| Executive dysfunction and cognitive impairment in a large community-based sample with Multiple Sclerosis from New Zealand: a descriptive study. | Q51970094 | ||
| Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. | Q51986202 | ||
| Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. | Q51998938 | ||
| The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. | Q52003567 | ||
| A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis. | Q52027902 | ||
| Brain atrophy in clinically early relapsing-remitting multiple sclerosis. | Q52046432 | ||
| Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. | Q52051437 | ||
| Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. | Q52093524 | ||
| Evaluating storage, retention, and retrieval in disordered memory and learning | Q52115465 | ||
| Benign multiple sclerosis | Q58452055 | ||
| T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis | Q44804838 | ||
| Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts | Q44816677 | ||
| Remyelination capacity of the MS brain decreases with disease chronicity | Q45353313 | ||
| Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
| Microglia as a critical player in both developmental and late-life CNS pathologies | Q30411278 | ||
| A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology | Q30525646 | ||
| Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration | Q30581773 | ||
| Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets | Q30814041 | ||
| Subcortical vascular cognitive impairment: similarities and differences with multiple sclerosis | Q31037155 | ||
| MRI relapses have significant pathologic and clinical implications in multiple sclerosis | Q31104823 | ||
| Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test | Q33520391 | ||
| Autoimmune T cell responses in the central nervous system | Q33620003 | ||
| Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis. | Q33630918 | ||
| Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology | Q33725086 | ||
| Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatric symptoms | Q33732239 | ||
| Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger | Q34321453 | ||
| Cognitive reserve and the neurobiology of cognitive aging | Q34367363 | ||
| Anterior nucleus of the thalamus: functional organization and clinical implications | Q34378984 | ||
| Subcortical dementia | Q34514234 | ||
| Remyelination can be extensive in multiple sclerosis despite a long disease course | Q34578773 | ||
| Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron | Q34607681 | ||
| Extensive cortical remyelination in patients with chronic multiple sclerosis. | Q34612670 | ||
| Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study | Q34623131 | ||
| Widespread demyelination in the cerebellar cortex in multiple sclerosis. | Q34627051 | ||
| Distribution of parvalbumin and calretinin immunoreactive interneurons in motor cortex from multiple sclerosis post-mortem tissue | Q34754753 | ||
| Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study | Q34926430 | ||
| Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. | Q34986741 | ||
| Oxidative damage in multiple sclerosis lesions | Q35065674 | ||
| Minimal neuropsychological assessment of MS patients: a consensus approach | Q35073778 | ||
| Cholinergic imbalance in the multiple sclerosis hippocampus | Q35200654 | ||
| Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis | Q35487283 | ||
| Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves | Q35487585 | ||
| Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity | Q35612500 | ||
| Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4 | Q35705851 | ||
| Inflammatory cortical demyelination in early multiple sclerosis | Q35764685 | ||
| Evolution of a neuroprotective function of central nervous system myelin | Q36117106 | ||
| Neurofascin as a novel target for autoantibody-mediated axonal injury | Q36228999 | ||
| Relevance of brain lesion location to cognition in relapsing multiple sclerosis | Q36373752 | ||
| Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. | Q36445604 | ||
| Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis | Q36454469 | ||
| Cortical remyelination: a new target for repair therapies in multiple sclerosis. | Q36504051 | ||
| Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) | Q36538213 | ||
| The incomplete nature of multiple sclerosis relapse resolution | Q36751380 | ||
| Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors | Q36920474 | ||
| Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. | Q37178774 | ||
| The relation between inflammation and neurodegeneration in multiple sclerosis brains. | Q37181308 | ||
| Taking ageing into account in remyelination-based therapies for multiple sclerosis | Q37186179 | ||
| Axon-glial signaling and the glial support of axon function | Q37193060 | ||
| Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. | Q37216153 | ||
| M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination | Q37687158 | ||
| Review: the architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis | Q37893199 | ||
| Clonal expansion of mitochondrial DNA deletions and the progression of multiple sclerosis | Q38009915 | ||
| Effects of acetylcholine in the striatum. Recent insights and therapeutic implications | Q38026828 | ||
| Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis | Q38034611 | ||
| Review: microglia of the aged brain: primed to be activated and resistant to regulation | Q38049597 | ||
| Multiple sclerosis and glutamate excitotoxicity. | Q38059846 | ||
| Adult neurogenesis in the dentate gyrus: general concepts and potential implications | Q38147067 | ||
| Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis | Q38399474 | ||
| The distribution of plaques in the cerebrum in multiple sclerosis | Q39412145 | ||
| Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology | Q39461074 | ||
| Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair | Q39833593 | ||
| Remyelination is extensive in a subset of multiple sclerosis patients. | Q40295868 | ||
| Subcortical dementia: a neurobehavioral approach | Q41115377 | ||
| Pathogenesis of leukoaraiosis: a review | Q41369515 | ||
| A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis | Q41494978 | ||
| Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients | Q41826954 | ||
| Effects of acute relapses on neuropsychological status in multiple sclerosis patients | Q42693551 | ||
| A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. | Q42847184 | ||
| Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. | Q43241664 | ||
| The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis | Q43426688 | ||
| Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery | Q43501432 | ||
| Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. | Q43611164 | ||
| Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. | Q43645390 | ||
| Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis | Q43806089 | ||
| White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis | Q43838103 | ||
| Paced auditory serial-addition task: a measure of recovery from concussion | Q43974735 | ||
| Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis | Q44043791 | ||
| Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients | Q44471617 | ||
| Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. | Q44620771 | ||
| Demyelination versus remyelination in progressive multiple sclerosis. | Q44651982 | ||
| P433 | issue | 1 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 79-98 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Brain Pathology | Q4955776 |
| P1476 | title | Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights | |
| P478 | volume | 25 |
| Q39013846 | Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis |
| Q49539768 | Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis-A Longitudinal Observational Study |
| Q41185707 | Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response |
| Q50103105 | Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis |
| Q48359324 | Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume. |
| Q58093629 | Brain activity pattern changes after adaptive working memory training in multiple sclerosis |
| Q49568258 | Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes. |
| Q90092001 | Changes in Cognitive Performance With Age in Adults With Multiple Sclerosis |
| Q89231024 | Cognition in older patients with multiple sclerosis compared to patients with amnestic mild cognitive impairment and healthy older adults |
| Q64950434 | Cognitive Dysfunctions and Assessments in Multiple Sclerosis. |
| Q64109778 | Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate |
| Q47165333 | Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): a study protocol for a randomised controlled trial |
| Q41947940 | Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis |
| Q37069057 | Correlation of MRI findings and cognitive function in multiple sclerosis patients using montreal cognitive assessment test |
| Q55282776 | Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis. |
| Q47640810 | Face-to-Face or Telematic Cognitive Stimulation in Patients with Multiple Sclerosis and Cognitive Impairment: Why Not Both? |
| Q47109436 | Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation. |
| Q58699005 | Identification of Cortical and Subcortical Correlates of Cognitive Performance in Multiple Sclerosis Using Voxel-Based Morphometry |
| Q102062612 | Impact of Cognitive Impairment and Dysarthria on Spoken Language in Multiple Sclerosis |
| Q64059582 | Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors |
| Q64972836 | Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis. |
| Q91210808 | Multiple sclerosis and cognition: synaptic failure and network dysfunction |
| Q40058208 | Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests |
| Q50054891 | Pediatric Multiple Sclerosis and Cognition: A Review of Clinical, Neuropsychologic, and Neuroradiologic Features. |
| Q53615466 | Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily. |
| Q48030031 | Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis |
| Q38948510 | Remotely Supervised Transcranial Direct Current Stimulation Increases the Benefit of At-Home Cognitive Training in Multiple Sclerosis |
| Q38871270 | Social Cognition in Multiple Sclerosis: a Meta-Analysis |
| Q33688161 | The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis |
| Q26796643 | Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management |
| Q48408132 | White matter damage in dementia. Introduction |
Search more.